Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2020

01-11-2020 | Knee-TEP | Review Paper

The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis

Authors: Catherine Steffens, BS, Minhee Sung, MD, Lori A. Bastian, MD, MPH, E. Jennifer Edelman, MD, MHS, Alexandria Brackett, MLS, Craig G. Gunderson, MD

Published in: Journal of General Internal Medicine | Issue 11/2020

Login to get access

Abstract

Background

In the current opioid epidemic, opioid addiction and overdose deaths are a public health crisis. Researchers have uncovered other concerning findings related to opioid use, such as the association between prescribed opioids and respiratory infection, including pneumonias. Potential mechanisms include the immunosuppressive effects of certain opioids, respiratory depression, and cough suppression. We conducted a systematic review assessing whether prescribed opioid receipt is a risk factor for community-acquired pneumonia (CAP).

Methods

A systematic literature search of published studies was conducted using Ovid MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL), Embase, Web of Science, AMED, and CINAHL from database inception through March 11, 2020. We included any clinical trial, cohort, or case–control study that reported an association between prescribed opioid receipt and CAP in adults. Two reviewers independently performed data extraction and quality assessment using the Newcastle-Ottawa Quality Assessment Scale. The risk of CAP from prescribed opioid receipt was studied by pooling studies using random effects meta-analysis.

Results

We identified 3229 studies after removing duplicates. After detailed selection, 33 articles were reviewed in full and eight studies (representing 567,472 patients) met inclusion criteria. The pooled effect for the four case–control studies and three cohort studies showed a significant increase in the risk of CAP requiring hospitalization among those with prescribed opioid receipt compared with those without opioid prescribed receipt (OR 1.57 [95% CI (1.34, 1.84)]; HR 1.18 [95% CI (1.00, 1.40)]).

Conclusion

The findings suggest prescribed opioid receipt is a risk factor for CAP. The included studies examined post-operative patients and patients with chronic medical conditions. Further research is needed to examine the impact of opioids on the incidence of CAP in an otherwise healthy population.
Appendix
Available only for authorised users
Literature
2.
go back to reference Tong S, Amand C, Kieffer A, Kyaw MH. Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008-2014. BMC Health Serv Res. 2018;18(1):715.PubMedPubMedCentral Tong S, Amand C, Kieffer A, Kyaw MH. Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008-2014. BMC Health Serv Res. 2018;18(1):715.PubMedPubMedCentral
3.
go back to reference Olson G, Davis AM. Diagnosis and treatment of adults with community-acquired pneumonia. JAMA. 2020. Olson G, Davis AM. Diagnosis and treatment of adults with community-acquired pneumonia. JAMA. 2020.
4.
go back to reference Arias E, Xu J, Kochanek KD. United States Life Tables, 2016. Natl Vital Stat Rep. 2019;68(4):1-66.PubMed Arias E, Xu J, Kochanek KD. United States Life Tables, 2016. Natl Vital Stat Rep. 2019;68(4):1-66.PubMed
5.
go back to reference Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of pneumonia: a systematic review and meta-analysis. BMJ Open. 2018;8(8):e022344.PubMedPubMedCentral Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of pneumonia: a systematic review and meta-analysis. BMJ Open. 2018;8(8):e022344.PubMedPubMedCentral
6.
go back to reference Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia. Med Clin North Am. 2019;103(3):487-501.PubMed Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia. Med Clin North Am. 2019;103(3):487-501.PubMed
7.
go back to reference Risdahl JM, Khanna KV, Peterson PK, Molitor TW. Opiates and infection. J Neuroimmunol. 1998;83(1-2):4-18.PubMed Risdahl JM, Khanna KV, Peterson PK, Molitor TW. Opiates and infection. J Neuroimmunol. 1998;83(1-2):4-18.PubMed
8.
go back to reference Roy S, Ninkovic J, Banerjee S, et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol. 2011;6(4):442-465.PubMedPubMedCentral Roy S, Ninkovic J, Banerjee S, et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol. 2011;6(4):442-465.PubMedPubMedCentral
9.
go back to reference Plein LM, Rittner HL. Opioids and the immune system—friend or foe. Br J Pharmacol. 2018;175(14):2717-2725.PubMed Plein LM, Rittner HL. Opioids and the immune system—friend or foe. Br J Pharmacol. 2018;175(14):2717-2725.PubMed
10.
go back to reference Edelman EJ, Gordon KS, Crothers K, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019;179(3):297-304.PubMedPubMedCentral Edelman EJ, Gordon KS, Crothers K, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019;179(3):297-304.PubMedPubMedCentral
11.
go back to reference Schaefer CP, Tome ME, Davis TP. The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse. Fluids Barriers CNS. 2017;14(1):32-11.PubMedPubMedCentral Schaefer CP, Tome ME, Davis TP. The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse. Fluids Barriers CNS. 2017;14(1):32-11.PubMedPubMedCentral
12.
go back to reference Dickinson RS, Morjaria JB, Wright CE, Morice AH. Is opiate action in cough due to sedation? Ther Adv Chronic Dis. 2014;5(5):200-205.PubMedPubMedCentral Dickinson RS, Morjaria JB, Wright CE, Morice AH. Is opiate action in cough due to sedation? Ther Adv Chronic Dis. 2014;5(5):200-205.PubMedPubMedCentral
13.
go back to reference Wang F, Roy S. Gut homeostasis, microbial dysbiosis, and opioids. Toxicol Pathol. 2017;45(1):150-156.PubMed Wang F, Roy S. Gut homeostasis, microbial dysbiosis, and opioids. Toxicol Pathol. 2017;45(1):150-156.PubMed
15.
go back to reference Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.PubMed Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.PubMed
16.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269, W264.PubMed Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269, W264.PubMed
18.
go back to reference DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.PubMed DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.PubMed
19.
20.
go back to reference Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med. 2003;22(17):2693-2710.PubMed Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med. 2003;22(17):2693-2710.PubMed
21.
go back to reference Dublin S, Walker RL, Jackson ML, et al. Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study. J Am Geriatr Soc. 2011;59(10):1899-1907.PubMedPubMedCentral Dublin S, Walker RL, Jackson ML, et al. Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study. J Am Geriatr Soc. 2011;59(10):1899-1907.PubMedPubMedCentral
22.
go back to reference Hamina A, Taipale H, Karttunen N, et al. Hospital-treated pneumonia associated with opioid use among community dwellers with Alzheimer’s disease. J Alzheimers Dis. 2019;69(3):807-816.PubMed Hamina A, Taipale H, Karttunen N, et al. Hospital-treated pneumonia associated with opioid use among community dwellers with Alzheimer’s disease. J Alzheimers Dis. 2019;69(3):807-816.PubMed
23.
go back to reference Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2016;48(3):683-693.PubMed Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2016;48(3):683-693.PubMed
24.
go back to reference Wiese AD, Griffin MR, Schaffner W, et al. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med. 2018;168(6):396-404.PubMedPubMedCentral Wiese AD, Griffin MR, Schaffner W, et al. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med. 2018;168(6):396-404.PubMedPubMedCentral
25.
go back to reference Kim SC, Jin Y, Lee YC, et al. Association of preoperative opioid use with mortality and short-term safety outcomes after total knee replacement. JAMA Netw Open. 2019;2(7):e198061.PubMedPubMedCentral Kim SC, Jin Y, Lee YC, et al. Association of preoperative opioid use with mortality and short-term safety outcomes after total knee replacement. JAMA Netw Open. 2019;2(7):e198061.PubMedPubMedCentral
26.
go back to reference Shah V, Hoang, N., Rodgers, B., Dornbos, D.L., Eaton, R., Pezzutti, D., Hoover, E., Duenas, H., Cua, S., Nimjee, S.M. The impact of preopertive opioids on outcomes in craniotomy patients. Clinical Neurosurgery 2019;66 (Supplement 1):160-161. Shah V, Hoang, N., Rodgers, B., Dornbos, D.L., Eaton, R., Pezzutti, D., Hoover, E., Duenas, H., Cua, S., Nimjee, S.M. The impact of preopertive opioids on outcomes in craniotomy patients. Clinical Neurosurgery 2019;66 (Supplement 1):160-161.
27.
go back to reference Velly AM, Steel, R, Karp, I, Morenz, E, Moulin, D, Morales, DR, Landry, J, Azoulay, L, Moldovan, F. The impact of opioids on the incidence of community-acquired pneumonia: a large nested case-control study. Annals of Epidemiology. 2017;27:520. Velly AM, Steel, R, Karp, I, Morenz, E, Moulin, D, Morales, DR, Landry, J, Azoulay, L, Moldovan, F. The impact of opioids on the incidence of community-acquired pneumonia: a large nested case-control study. Annals of Epidemiology. 2017;27:520.
28.
go back to reference Wiese AD, Griffin MR, Schaffner W, et al. Long-acting opioid use and the risk of serious infections: a retrospective cohort study. Clin Infect Dis. 2019;68(11):1862-1869.PubMed Wiese AD, Griffin MR, Schaffner W, et al. Long-acting opioid use and the risk of serious infections: a retrospective cohort study. Clin Infect Dis. 2019;68(11):1862-1869.PubMed
29.
go back to reference Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care. 2008;2(1):14-18.PubMed Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care. 2008;2(1):14-18.PubMed
30.
go back to reference Boland JW, McWilliams K, Ahmedzai SH, Pockley AG. Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review. Br J Cancer. 2014;111(5):866-873.PubMedPubMedCentral Boland JW, McWilliams K, Ahmedzai SH, Pockley AG. Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review. Br J Cancer. 2014;111(5):866-873.PubMedPubMedCentral
Metadata
Title
The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis
Authors
Catherine Steffens, BS
Minhee Sung, MD
Lori A. Bastian, MD, MPH
E. Jennifer Edelman, MD, MHS
Alexandria Brackett, MLS
Craig G. Gunderson, MD
Publication date
01-11-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 11/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06155-9

Other articles of this Issue 11/2020

Journal of General Internal Medicine 11/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.